Microsoft announced Thursday that it has acquired Citus Data, a startup that uses PostgreSQL, a database management system that’s popular with developers. This move is another sign that Microsoft is investing in open source technologies, and follows its $US7.5 billion acquisition of GitHub last year. This acquisition could also give Microsoft Azure an edge over Amazon Web Services as it would help Microsoft with running open source workloads with more power and scale. Not too long after its $US7.5 billion acquisition of GitHub last year, Microsoft is adding another startup to its growing open source software empire: Citus Data. On Thursday, Microsoft announced it has acquired Citus Data, an open source database startup. Cirus Data was first founded in 2010, and raised a relatively meager $US13.2 million in venture capital funding in that time. It was an early graduate from the Y Combinator startup incubator program, and attracted investors including SV Angel, Khosla … [Read more...] about Microsoft buys an open source database startup to give it an edge against Amazon Web Services
Application performance management open source
Institut Curie Names Intel Lead Partner to Implement High-Performance Computing and Artificial Intelligence in Accelerating Genome Sequencing and Interpretation for Oncology
PARIS--(BUSINESS WIRE)--May 23, 2018--Institut Curie and Intel initiate a pioneering collaboration to develop, use and implement innovative bioinformatics tools, pipelines and techniques to improve the use of molecular profiling across both research and clinical oncology settings.Precision medicine for cancer requires the delivery of individually adapted medical care based on the genetic characteristics of each patient. The last decade witnessed the development of high-throughput technologies such as next-generation sequencing, which paved their way in the field of oncology. While the cost of these technologies decreases, we are facing an exponential increase in the amount of data produced. In order to open access to precision medicine-based therapies to more patients, healthcare providers have to rationalize both their data production and utilization. This requires the implementation of cutting-edge technologies: high-performance computing and artificial intelligence (AI).Before … [Read more...] about Institut Curie Names Intel Lead Partner to Implement High-Performance Computing and Artificial Intelligence in Accelerating Genome Sequencing and Interpretation for Oncology
Women’s Tennis Association to Use Masimo MightySat™ Fingertip Pulse Oximeters to Advance Player Health and Performance
ST. PETERSBURG, Fla. & IRVINE, Calif.--(BUSINESS WIRE)--May 21, 2018--The Women’s Tennis Association (WTA) and Masimo (NASDAQ: MASI) announced today that the WTA’s Sport Sciences and Medicine (SS&M) team will immediately begin using Masimo MightySat™ as part of their mission to provide comprehensive care for athletes on the women’s professional tennis circuit.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005347/en/Masimo MightySat™ (Photo: Business Wire)MightySat is a fingertip pulse oximeter designed for general wellness and health applications including sports, fitness, and relaxation management. MightySat provides noninvasive measurements of oxygen saturation (SpO 2 ), pulse rate (PR), perfusion index (Pi), PVi ® (studies show changes in PVi may indicate changes in hydration, breathing effort, perfusion, or other factors 1-3 ) and RRp™ (respiration rate based on the … [Read more...] about Women’s Tennis Association to Use Masimo MightySat™ Fingertip Pulse Oximeters to Advance Player Health and Performance
Bioverativ and Sangamo Announce FDA Acceptance of IND Application for Gene-Edited Cell Therapy BIVV003 to Treat Sickle Cell Disease
WALTHAM, Mass. & RICHMOND, Calif.--(BUSINESS WIRE)--May 16, 2018--Bioverativ Inc., a Sanofi company dedicated to transforming the lives of people with rare blood disorders, and Sangamo Therapeutics, Inc. (NASDAQ:SGMO) announced today that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for BIVV003, a gene-edited cell therapy candidate for the treatment of people with sickle cell disease. Bioverativ and Sangamo are developing BIVV003 as part of an exclusive worldwide collaboration to develop and commercialize gene-edited cell therapies for sickle cell disease and beta thalassemia.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180516005404/en/“This acceptance marks the second IND for this gene-editing approach in less than a year, and the first for a gene-edited therapy in sickle cell disease,” said Ken Huttner, M.D. Ph.D., Vice President, Clinical … [Read more...] about Bioverativ and Sangamo Announce FDA Acceptance of IND Application for Gene-Edited Cell Therapy BIVV003 to Treat Sickle Cell Disease
ADTRAN to Lead Broadband Forum’s Advanced Application-Level Traffic Generation Testing
HUNTSVILLE, Ala.--(BUSINESS WIRE)--May 14, 2018--ADTRAN ®, Inc., (NASDAQ:ADTN), the leading provider of next-generation open networking solutions, today announced it is leading an initiative within the Broadband Forum that will leverage application-level traffic generation for advanced broadband testing. This is driven by migration to NFV-based systems creating a new requirement for a standardized approach to testing of dynamically reconfigured virtualized services, which can challenge traditional methods of performance characterization.“This initiative will benefit service providers, vendors and testing labs by fundamentally allowing them to manage the increasingly complex subscriber traffic on the network as application and service parameters change and evolve,” Broadband Forum CEO Robin Mersh said. “The project stream will have far-reaching positive effects on the entire industry and is why the Broadband Forum is championing it. ADTRAN’s domain … [Read more...] about ADTRAN to Lead Broadband Forum’s Advanced Application-Level Traffic Generation Testing